Inhibition by a CD14 monoclonal antibody of lipopolysaccharide binding to murine macrophages

Journal of Endotoxin Research

Volumn 5, Issue 3, 1999, Pages 139-146

  Adachi, Y ^a   Satokawa, C ^a   Saeki, M ^a   Ohno, N ^a   Tamura, H ^b   Tanaka, S ^b   Yadomae, T ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b SEIKAGAKU CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CASEIN; CD14 ANTIGEN; COMPLEMENTARY DNA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; NITRITE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE C; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BONE MARROW; CELL LYSATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPRESSION VECTOR; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MOLECULAR WEIGHT; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MACROPHAGE;

ANIMALIA; MURINAE;

EID: 0032843481     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805199101531642     Document Type: Article

References (27)

1. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
2. Ulevitch RJ, Mathison JC, Schumann RR, Tobias PS. A new model of macrophage stimulation by bacterial lipopolysaccharide. J Trauma 1990; 30: S189-S192.
3. Wright SD, Ramos RA, Hermanowski-Vosatka A, Rockwell P, Detmers PA. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med 1991; 173: 1281-1286.
4. Yu B, Wright SD. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J Biol Chem 1996; 271: 4100-4105.
5. Heumann D, Gallay P, Barras C et al. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J Immunol 1992; 148: 3505-3512.
6. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996; 64: 1906-1912.
7. Savedra Jr R, Delude RL, Ingalls RR, Fenton MJ, Golenbock DT. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. J Immunol 1996; 157: 2549-2554.
8. Kusunoki T, Wright SD. Chemical characteristics of Staphylococcus aureus molecules that have CD14-dependent cell-stimulating activity. J Immunol 1996; 157: 5112-5117.
9. Weidemann B, Schletter J, Dziarski R et al. Specific binding of soluble peptidoglycan and muramyldipcptide to CD14 on human monocytes. Infect Immun 1997; 65: 858-864.
10. Bosco MC, Espinoza-Delgado I, Rowe TK, Malabarba MG, Longo DL, Varesio L. Functional role for the mycloid differentiation antigen CD14 in the activation of human monocytes by IL-2. J Immunol 1997; 159: 2922-2931.
11. Wang PY, Kitchens RL, Munford RS. Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J Biol Chem 1998; 273: 24309-24313.
12. Schimke J, Mathison J, Morgiewicz J, Ulevitch RJ. Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci USA 1998; 95: 13875-13880.
13. Adachi Y, Suzuki Y, Ohno N, Yadomae T. Adjuvant effect of grifolan on antibody production in mice. Biol Pharm Bull 1998; 21: 974-977.
14. Matsuura K, Ishida T, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S. Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. J Exp Med 1994; 179: 1671-1676.
15. Yang RB, Mark MR, Gray A et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 1998; 395: 284-288.
16. Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 1998; 188: 2091-2097.
17. Schumann RR. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review. Res Immunol 1992; 143: 11-15.
18. Goyert SM, Hazio A, Jiao D et al. CD14 cluster workshop report. Leukocyte Typing V 1995; 778-782.
19. Yamamoto S, Matsuura K, Ishida T et al. Characterization and use of mAb against mouse CD14. Leukocyte Typing V 1995; 788-790.
20. Perera PY, Vogel SN, Detore GR, Haziot A, Goyert SM. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J Immunol 1997; 158: 4422-4429.
21. Vogel SN, Perera PY, Detore GR et al. CD14 dependent and independent signaling pathways in murine macrophages from normal and CD14 'knockout' (CD14KO) mice stimulated with LPS or taxol. Prog Clin Biol Res 1998; 397: 137-146.
22. Yamamoto S, Tamura Y, Higuchi Y et al. Roles of CD14 in LPS signaling and scavenging: analysis of CD14-transgenic and nontransgenic mice and rats in response to LPS. Prog Clin Biol Res 1998; 397: 89-96.
23. Hetherington CJ, Kingsley PD, Crocicchio F et al.. Characterization of human endotoxin lipopolysaccharide receptor CD14 expression in transgenic mice. J Immunol 1999; 162: 503-509.
24. Pedron T, Girard R, Chaby R. Variation of LPS-binding capacity, epitope expression, and shedding of membrane-bound CD14 during differentiation of human monocytes. J Immunol 1995; 155: 1460-1471.
25. Stelter F, Bernheiden M, Menzel R et al. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur J Biochem 1997; 243: 100-109.
26. Juan TS, Hailman E, Kelley MJ et al. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J Biol Chem 1995; 270: 5219-5224.
27. Kirikae F, Kirikae T, Qureshi N, Takayama K, Morrison DC, Nakano M. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infect Immun 1995; 63: 486-497.